Thomas Gerald, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Rd, Tripler Amc, HI 96859 Phone: 806-681-6541 |
Ernesto Montecillo Padilla, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center Attn:mchk-qs, Tripler Amc, HI 96859 Phone: 808-433-2460 |
Dr. Richard S. Stack, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Attn: Mchk-qs, Tripler Amc, HI 96859 Phone: 808-433-2460 Fax: 808-433-1558 |
Dr. William Gilliam Kennon Iii, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Tripler Amc, HI 96859 Phone: 808-433-2460 Fax: 808-433-1558 |
News Archive
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
Pomegranates have already been hailed as a super-food but a team of scientists from Kingston University in South West London has found a new use for the deep red fruit. The team, led by Professor Declan Naughton, has discovered that the rind can be turned into an ointment for treating MRSA and other common hospital infections.
The metropolitan Washington, D.C. region currently experiences health inequities related to access to care in underserved areas, disparities in chronic disease outcomes, provider shortages, and inadequate diversity of the health professions. Research has shown that a more diverse health care workforce can help address these problems.
This post on IntraHealth International's "Global Health Blog" discusses a new report from the WHO, titled "Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination," which "concludes that 'all countries should commit to spend at least 0.01 percent of GDP on government-funded R&D [research and development] devoted to meeting the health needs of developing countries.'"
› Verified 3 days ago